|
|
???tair.name??? >
???browser.page.title.author???
|
"ann lii cheng"???jsp.browse.items-by-author.description???
Showing items 606-630 of 690 (28 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T09:22:43Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Ou, Da-Liang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Ou, D.-L. and Lin, L.-I. and Tseng, L.-H. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; Lin, Yu-Lin; LI-HUI TSENG; Lin, Yu-Lin; Liau, Jau-Yu; YIH-LEONG CHANG; JAU-YU LIAU; Yu, Shan-Chi; Ou, Da-Liang; DA-LIANG OU; Ou, Da-Liang; LIANG-IN LIN; Lin, Liang-In; Lin, Liang-In; Tseng, Li-Hui; KUN-HUEI YEH; Tseng, Li-Hui; Chang, Yih-Leong; YU-LIN LIN; Yeh, Kun-Huei; ANN-LII CHENG; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:16:02Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu, Chiun;Shen, Ying-Chun;Cheng, Chia-Chi;Cheng, Ann-Lii;Hu, Fu-Chang;Yeh, Kun-Huei; Hsu, C. and Shen, Y.-C. and Cheng, C.-C. and Cheng, A.-L. and Hu, F.-C. and Yeh, K.-H.; 鄭安理 ;許駿 ;葉坤輝; Hsu, Chiun; KUN-HUEI YEH; Hsu, Chiun; Shen, Ying-Chun; ANN-LII CHENG; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Hu, Fu-Chang; Yeh, Kun-Huei; Yeh, Kun-Huei |
| 臺大學術典藏 |
2018-09-10T09:15:58Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
CHIUN-SHENG HUANG; Lin, Ching-Hung; Chen, Yong-Chen; WEN-FANG CHENG; CHING-HUNG LIN; CHIANG,CHUN-JU; KUAN-TING KUO; Lu, Yen-Shen; ANN-LII CHENG; Kuo, Kuan-Ting; Huang, Chiun-Sheng; Cheng, Wen-Fang; Lai, Mei-Shu; You, San-Lin; Cheng, Ann-Lii; 鄭文芳 ;盧彥伸 ;賴美淑 ;郭冠廷 ;鄭安理 ;黃俊升 ;林璟宏; Lin, Ching-Hung;Chen, Yong-Chen;Chiang, Chun-Ju;Lu, Yen-Shen;Kuo, Kuan-Ting;Huang, Chiun-Sheng;Cheng, Wen-Fang;Lai, Mei-Shu;You, San-Lin;Cheng, Ann-Lii; Lin, Ching-Hung;Chen, Yong-Chen;Chiang, Chun-Ju;Lu, Yen-Shen;Kuo, Kuan-Ting;Huang, Chiun-Sheng;Cheng, Wen-Fang;Lai, Mei-Shu;You, San-Lin;Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:33:58Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Yang, S.-H. and Kuo, Y.-H. and Tien, Y.-W. and Hsu, C. and Hsu, C.-H. and Kuo, S.-H. and Cheng, A.-L.; CHIH-HUNG HSU; Sung-Hsin Kuo; YU-WEN TIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:33:58Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang, H.-J. and Lin, Y.-L. and Wang, H.-P. and Chiu, Y.-F. and Chang, M.-C. and Hsu, C.-H. and Tien, Y.-W. and Chen, J.-S. and Hsieh, R.-K. and Lin, P.-W. and Shan, Y.-S. and Cheng, A.-L. and Chang, J.-Y. and Whang-Peng, J. and Hwang, T.-L. and Chen, L.-T.; CHIH-HUNG HSU; YU-WEN TIEN; YU-LIN LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:32:52Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, J.-S. and Chao, Y. and Hsieh, R.-K. and Cheng, A.-L. and Chen, P.-M. and Chiou, T.-J. and Chao, T.-Y. and Yeh, K.-H. and Chen, L.-T. and Whang-Peng, J.; 陳仁熙;趙毅;鄭安理;陳博明;邱宗傑;趙祖怡;葉坤輝;陳立宗;彭汪嘉康; CHEN, JEN-SHI;CHAO, YEE;CHENG, ANN-LII;CHEN, PO-MIN;CHIOU, TZEON-JYE;CHAO, TSU-YI;YEH, KUN-HUEI;CHEN, LI-TZONG;WHANG-PENG, JACQUELINE; KUN-HUEI YEH; ANN-LII CHENG; CHEN, JEN-SHI; CHAO, YEE; CHENG, ANN-LII; CHEN, PO-MIN; CHIOU, TZEON-JYE; CHAO, TSU-YI; YEH, KUN-HUEI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE |
| 臺大學術典藏 |
2018-09-10T08:32:44Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Chen, I.C.; Lin, C.H.; Huang, C.S.; Lien, H.C.; Hsu, C.; Kuo, W.H.; Lu, Y.S.; Cheng, A.L.; CHIUN-SHENG HUANG; CHING-HUNG LIN; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:31:21Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho, Y.-F. Lu, W.-C. Chen, R.R.-L. Cheng, A.-L. Yeh, K.-H.; KUN-HUEI YEH; YUNN-FANG HO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:56Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, S.-H. and Cheng, A.-L. and Lin, C.-W. and Hsu, C.-H. and Wu, M.-S. and Yeh, K.-H. and Tzeng, Y.-S. and Chen, L.-T.; CHIH-HUNG HSU; Sung-Hsin Kuo; CHUNG-WU LIN; KUN-HUEI YEH; MING-SHIANG WU; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:12Z |
Recent advances in the treatment of metastatic colorectal cancer in Taiwan
|
Lin, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH; YU-LIN LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:21:44Z |
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
|
Lin, C.-H. and Lien, H.-C. and Hu, F.-C. and Lu, Y.-S. and Kuo, S.-H. and Wu, L.-C. and You, S.-L. and Cheng, A.-L. and Chang, K.-J. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHING-HUNG LIN; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:06:38Z |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yen, R.-F. and Lin, C.-W. and Chen, L.-T. and Tien, H.F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; RUOH-FANG YEN; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:37Z |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells
|
Weng, Y.-I.;Hsu, P.-Y.;Liyanarachchi, S.;Liu, J.;Deatherage, D.E.;Huang, Y.-W.;Zuo, T.;Rodriguez, B.;Lin, C.-H.;Cheng, A.-L.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:36Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu, Pei-Fang;Kuo, Kuan-Ting;Kuo, Lu-Ting;Lin, Yi-Ting;Lee, Wei-Chung;Lu, Yen-Shen;Yang, Chih-Hsin;Wu, Ruey-Meei;Tu, Yong-Kwang;Tasi, Jui-Chang;Tseng, Ham-Min;Tseng, Sheng-Hong;Cheng, Ann-Lii;Lin, Ching-Hung; Wu, Pei-Fang; Ruey-Meei Wu; Lu-Ting Kuo; Kuo, Kuan-Ting; Kuo, Lu-Ting; Yong-Kwang Tu; Lin, Yi-Ting; CHING-HUNG LIN; KUAN-TING KUO; Lee, Wei-Chung; ANN-LII CHENG; Lu, Yen-Shen; Yang, Chih-Hsin; Wu, Ruey-Meei; Tu, Yong-Kwang; Tasi, Jui-Chang; Tseng, Ham-Min; Tseng, Sheng-Hong; Cheng, Ann-Lii; Lin, Ching-Hung |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:03:10Z |
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
|
Lin, Z.-Z. and Jeng, Y.-M. and Hu, F.-C. and Pan, H.-W. and Tsao, H.-W. and Lai, P. and Lee, P. and Cheng, A.-L. and Hsu, H.-C.; PO-HUANG LEE; YUNG-MING JENG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou, C.H. and Chen, P.-J. and Jeng, Y.-M. and Cheng, A.-L. and Huang, L.-R. and Cheng, J.C.-H.; YUNG-MING JENG; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:26:16Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, H.-J. and Huang, C.-L. and Wang, H.-P. and Shiah, H.-S. and Chang, M.-C. and Jan, C.-M. and Chen, J.-S. and Tien, Y.-W. and Hwang, T.-L. and Lin, J.-T. and Cheng, A.-L. and Whang-Peng, J. and Chen, L.-T.; YU-WEN TIEN; ANN-LII CHENG |
Showing items 606-630 of 690 (28 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page
|
